NANETS Regional NET Education: The Multidisciplinary Management of NET Cancers

CME/CE Certified Activity
Saturday, November 10, 2018
7:00am – 4:00pm 


Register Here


Hilton Garden Inn – New Orleans Convention Center
1001 South Peters Street
New Orleans, LA 70130

Directions and parking information available here.


Jointly Provided by Ochsner Clinic Foundation and North American Neuroendocrine Tumor Society.


Neuroendocrine tumors (NET) are considered to be a rare disease although the frequency of diagnosis has increased over the last ten years. As this is a rare disease, clinicians often do not know how to implement the appropriate care plan and until the last ten years there was great variability in terms of treatment. The diagnosis, treatment and management of NETs are time consuming, complex and require a multidisciplinary approach. Many healthcare providers who face these challenges are not adequately equipped in their knowledge or experience optimally manage NET disease.

The field of NET research has been evolving with new drug approvals and treatment modalities. In addition, experts in the field of NET disease have continued to develop strategies to improve diagnosis, treatment and management of NET cancers. It is through convening professionals in the areas of oncology, gastroenterology, pulmonology, surgery, radiology and allied fields that the awareness and understanding of NET diseases will expand, resulting in better treatment for NET patients.

Target Audience

This activity is designed for oncologists, gastroenterologists, pulmonologists, surgeons, radiologists, pathologists, primary care physicians, advanced practice nurses, nurses, physician assistants, pharmacists, fellows, students, and other allied health professionals involved with or interested in the treatment of patients with neuroendocrine tumors.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Review current concepts of neuroendocrine tumor pathology, molecular profile, classification, and grading
  • Discuss the various diagnostic processes and use of current and emerging diagnostic tools to determine neuroendocrine tumor type
  • Summarize the current safety and efficacy data of the various surgical, medical and loco-regional approaches in the management of neuroendocrine tumors
  • Recognize the clinical features associated with carcinoid syndrome
  • Apply a multidisciplinary approach to the management of patients with neuroendocrine tumors
  • Review clinical trial data and ongoing studies evaluating novel management strategies for the treatment of neuroendocrine tumors


7:00 - 8:00 am - Registration and Breakfast
7:55 - 8:00 am - Welcome and Opening Remarks - Robert Ramirez, DO, FACP, Ochsner Medical Center

8:00 - 9:30 am - Overview of NETs

Moderator: Eugene Woltering, MD, FACS, Louisiana State University

  • When you Hear Hoof Beats…Overview of Neuroendocrine Tumors: Epidemiology, Symptoms and Diagnosis - Thomas O’Dorisio, MD, University of Iowa
  • Pathology of NETs: Current State and Controversies - Laura Tang, MD, Memorial Sloan Kettering Cancer Center
  • The Role of CT, MRI, Octreotide, Gallium-68 PET/CT and I-123-MIBG Scans in Work Up and Surveillance of NETs: What to Use and When - Richard Marshall, MD, Louisiana State University
  • Panel Discussion 

9:30 – 9:45 am - Break and Networking

9:45 - 12:00 pm - Surgical and Medical Management of NETs

Moderator: Robert Ramirez, DO, FACP, Ochsner Medical Center

  • Medical Management of Low-Grade NETs: What to do Beyond Somatostatin Analogs - Scott Paulson, MD, Texas Oncology Baylor Charles A. Sammons Cancer Center
  • Medical Management of High-Grade NETs and Neuroendocrine Carcinoma - Lowell Anthony, MD, University of Kentucky
  • 1000 Cytoreductions for Advanced stage NETs: Results, Indications, Outcomes. - J. Philip Boudreaux, MD, FACS, Louisiana State University
  • Peptide Receptor Radionuclide Therapy: Where We Are and Where We Are Going - Jonathan Strosberg, MD, Moffit Cancer Center
  • Panel Discussion
  • Multidisciplinary Neuroendocrine Tumor Board

12:00 - 1:00 pm - Lunch and Networking

*12:00 - 1:00 pm Lunch Session for Nurses - The Role of the NET Nurse Navigator - Pamela Ryan, BSN, RN, ONN-CG, Ochsner Medical Center*

1:00 - 2:15 pm - Additional Topics

Moderator: J. Philip Boudreaux, MD, FACS, Louisiana State University

  • The Role of Biomarkers in Pancreatic and Small Bowel NETs - Eugene Woltering, MD, FACS, Louisiana State University
  • Overview of NETs of the Lung: Diagnosis and Medical Management - Robert Ramirez, DO, FACP, Ochsner Medical Center
  • The Surgical and Interventional Management of Pulmonary Carcinoids - Brian Pettiford, MD, Ochsner Medical Center
  • Panel Discussion

2:15 - 2:30 pm - Break and Networking

2:30 - 3:55 pm - Additional Topics 2  

Moderator: Scott Paulsen, MD, Texas Oncology Baylor Charles A. Sammons Cancer Center

  • Surgical Management of Appendiceal NETs - Ramcharan Thiagarajan, MD, FACS, Louisiana State University
  • The Role of Interventional Radiologist in the Management of NETs: Liver-Directed Therapy - Juan Gimenez, MD, Ochsner Medical Center
  • The Nutritional Aspects of Patients Living with NETs - Leigh Anne Burns, RD, Louisiana State University
  • Panel Discussion

3:55 - 4:00 pm - Closing RemarksRobert Ramirez, DO, FACP, Ochsner Health System


The Ochsner Clinic Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Ochsner Clinic Foundation designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Ochsner Health System, Nursing Professional Development is an approved provider of continuing nursing education by Louisiana State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Method of Participation

In order to meet the learning objectives and receive continuing education credit for this activity, participants are required to check in at the registration desk, attend the activity, and complete the online evaluation form at the conclusion of the activity. A letter certifying attendance and credit verification will be mailed to participants upon completion of the online evaluation survey.


Online registration available.
In-person registration available onsite on day of program and will be accommodated on a space-available basis

Registration fee:
$65 - MD, PharmD, Doctoral Level 
$35 - Allied Health
Complimentary - Student/Fellow/Resident

Cancellation Policy: A full refund will be made if registration is canceled, in writing, on or before September 10, 2018. On or after September 10, 2018, no refund will be made.

Rutgers Biomedical and Health Sciences and North American Neuroendocrine Tumor Society reserve the right to modify the activity content, faculty, and activities and reserve the right to cancel this activity if necessary. If the program is cancelled, liability is limited to the registration fee.


Please contact us with any questions.